Cartilage Regeneration in Human with Adipose Tissue-Derived Stem Cells: Current Status in Clinical Implications

Jaewoo Pak, Jung Hun Lee, Wiwi Andralia Kartolo, Sang Hee Lee, Jaewoo Pak, Jung Hun Lee, Wiwi Andralia Kartolo, Sang Hee Lee

Abstract

Osteoarthritis (OA) is one of the most common debilitating disorders among the elderly population. At present, there is no definite cure for the underlying causes of OA. However, adipose tissue-derived stem cells (ADSCs) in the form of stromal vascular fraction (SVF) may offer an alternative at this time. ADSCs are one type of mesenchymal stem cells that have been utilized and have demonstrated an ability to regenerate cartilage. ADSCs have been shown to regenerate cartilage in a variety of animal models also. Non-culture-expanded ADSCs, in the form of SVF along with platelet rich plasma (PRP), have recently been used in humans to treat OA and other cartilage abnormalities. These ADSCs have demonstrated effectiveness without any serious side effects. However, due to regulatory issues, only ADSCs in the form of SVF are currently allowed for clinical uses in humans. Culture-expanded ADSCs, although more convenient, require clinical trials for a regulatory approval prior to uses in clinical settings. Here we present a systematic review of currently available clinical studies involving ADSCs in the form of SVF and in the culture-expanded form, with or without PRP, highlighting the clinical effectiveness and safety in treating OA.

Figures

Figure 1
Figure 1
Literature selection process (PRISMA flow diagram).

References

    1. Simon L. S. Osteoarthritis. Current Rheumatology Reports. 1999;1(1):45–47. doi: 10.1007/s11926-999-0024-2.
    1. Buckwalter J. A. Articular cartilage injuries. Clinical Orthopaedics and Related Research. 2002;402(1):21–37.
    1. Belmont P. J., Jr., Goodman G. P., Waterman B. R., Bader J. O., Schoenfeld A. J. Thirty-day postoperative complications and mortality following total knee arthroplasty: incidence and risk factors among a national sample of 15,321 patients. The Journal of Bone and Joint Surgery. 2014;96(1):20–26. doi: 10.2106/jbjs.m.00018.
    1. Aynardi M., Pulido L., Parvizi J., Sharkey P. F., Rothman R. H. Early mortality after modern total hip arthroplasty. Clinical Orthopaedics and Related Research. 2009;467(1):213–218. doi: 10.1007/s11999-008-0528-5.
    1. Glyn-Jones S., Palmer A. J., Agricola R., et al. Osteoarthritis. The Lancet. 2015;386(9991):376–387. doi: 10.1016/S0140-6736(14)60802-3.
    1. Arnoczky S. P. Building a meniscus. Biologic considerations. Clinical Orthopaedics and Related Research. 1999;367, supplement:S244–S253.
    1. Szilvassy S. J. The biology of hematopoietic stem cells. Archives of Medical Research. 2003;34(6):446–460. doi: 10.1016/j.arcmed.2003.06.004.
    1. Caplan A. I. Mesenchymal stem cells. Journal of Orthopaedic Research. 1991;9(5):641–650. doi: 10.1002/jor.1100090504.
    1. Carter D. R., Beaupré G. S., Giori N. J., Helms J. A. Mechanobiology of skeletal regeneration. Clinical Orthopaedics and Related Research. 1998;355(supplement):S41–S55.
    1. Johnstone B., Yoo J. U. Autologous mesenchymal progenitor cells in articular cartilage repair. Clinical Orthopaedics and Related Research. 1999;(367) supplement:S156–S162.
    1. Centeno C. J., Busse D., Kisiday J., Keohan C., Freeman M., Karli D. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician. 2008;11(3):343–353.
    1. Centeno C. J., Schultz J. R., Cheever M., Robinson B., Freeman M., Marasco W. Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Current Stem Cell Research & Therapy. 2010;5(1):81–93. doi: 10.2174/157488810790442796.
    1. Zuk P. A., Zhu M., Mizuno H., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Engineering. 2001;7(2):211–228. doi: 10.1089/107632701300062859.
    1. Zuk P. A., Zhu M., Ashjian P., et al. Human adipose tissue is a source of multipotent stem cells. Molecular Biology of the Cell. 2002;13(12):4279–4295. doi: 10.1091/mbc.e02-02-0105.
    1. Toghraie F., Razmkhah M., Gholipour M. A., et al. Scaffold-free adipose-derived stem cells (ASCs) improve experimentally induced osteoarthritis in rabbits. Archives of Iranian Medicine. 2012;15(8):495–499.
    1. Black L. L., Gaynor J., Gahring D., et al. Effect of adipose-derived mesenchymal stem and regenerative cells on lameness in dogs with chronic osteoarthritis of the coxofemoral joints: a randomized, double-blinded, multicenter, controlled trial. Veterinary Therapeutics. 2007;8(4):272–284.
    1. Guercio A., Di Marco P., Casella S., et al. Production of canine mesenchymal stem cells from adipose tissue and their application in dogs with chronic osteoarthritis of the humeroradial joints. Cell Biology International. 2012;36(2):189–194. doi: 10.1042/CBI20110304.
    1. Frisbie D. D., Kisiday J. D., Kawcak C. E., Werpy N. M., McIlwraith C. W. Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis. Journal of Orthopaedic Research. 2009;27(12):1675–1680. doi: 10.1002/jor.20933.
    1. Lee J.-M., Im G.-I. SOX trio-co-transduced adipose stem cells in fibrin gel to enhance cartilage repair and delay the progression of osteoarthritis in the rat. Biomaterials. 2012;33(7):2016–2024. doi: 10.1016/j.biomaterials.2011.11.050.
    1. Pak J. Regeneration of human bones in hip osteonecrosis and human cartilage in knee osteoarthritis with autologous adipose-tissue-derived stem cells: a case series. Journal of Medical Case Reports. 2011;7(5, article 296) doi: 10.1186/1752-1947-5-296.
    1. Jo C. H., Lee Y. G., Shin W. H., et al. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial. STEM CELLS. 2014;32(5):1254–1266. doi: 10.1002/stem.1634.
    1. Koh Y.-G., Choi Y.-J., Kwon S.-K., Kim Y.-S., Yeo J.-E. Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis. Knee Surgery, Sports Traumatology, Arthroscopy. 2015;23(5):1308–1316. doi: 10.1007/s00167-013-2807-2.
    1. Koh Y. G., Choi Y. J., Kwon O. R., Kim Y. S. Second-look arthroscopic evaluation of cartilage lesions after mesenchymal stem cell implantation in osteoarthritic knees. American Journal of Sports Medicine. 2014;42(7):1628–1637. doi: 10.1177/0363546514529641.
    1. Nakagami H., Maeda K., Morishita R., et al. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25(12):2542–2547. doi: 10.1161/01.atv.0000190701.92007.6d.
    1. Cai L., Johnstone B. H., Cook T. G., et al. Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization. STEM CELLS. 2007;25(12):3234–3243. doi: 10.1634/stemcells.2007-0388.
    1. Mizuno K., Muneta T., Morito T., et al. Exogenous synovial stem cells adhere to defect of meniscus and differentiate into cartilage cells. Journal of Medical and Dental Sciences. 2008;55(1):101–111.
    1. Ong E., Chimutengwende-Gordon M., Khan W. Stem cell therapy for knee ligament, articular cartilage and meniscal injuries. Current Stem Cell Research & Therapy. 2013;8(6):422–428. doi: 10.2174/1574888x1130800059.
    1. Caplan A. I., Dennis J. E. Mesenchymal stem cells as trophic mediators. Journal of Cellular Biochemistry. 2006;98(5):1076–1084. doi: 10.1002/jcb.20886.
    1. Yeo R. W. Y., Lai R. C., Tan K. H., Lim S. K. Exosome: a novel and safer therapeutic refinement of mesenchymal stem cell. Exosomes and Microvesicles. 2013;1(7):1–12.
    1. Ferro F., Spelat R., Falini G., et al. Adipose tissue-derived stem cell in vitro differentiation in a three-dimensional dental bud structure. The American Journal of Pathology. 2011;178(5):2299–2310. doi: 10.1016/j.ajpath.2011.01.055.
    1. Moher D., Liberati A., Tetzlaff J., Altman D. G. The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of Internal Medicine. 2009;151(4):264–269.
    1. Ministry of Food and Drug Safety (MFDS) Cell Therapy: Rules and Regulations. Seoul, South Korea: MFDS; 2009, .
    1. Ryu Y.-J., Cho T.-J., Lee D.-S., Choi J.-Y., Cho J. Phenotypic characterization and in vivo localization of human adipose-derived mesenchymal stem cells. Molecules and Cells. 2013;35(6):557–564. doi: 10.1007/s10059-013-0112-z.
    1. De Ugarte D. A., Morizono K., Elbarbary A., et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs. 2003;174(3):101–109. doi: 10.1159/000071150.
    1. Aust L., Devlin B., Foster S. J., et al. Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy. 2004;6(1):7–14. doi: 10.1080/14653240310004539.
    1. Oedayrajsingh-Varma M. J., van Ham S. M., Knippenberg M., et al. Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure. Cytotherapy. 2006;8(2):166–177. doi: 10.1080/14653240600621125.
    1. Zhu Y., Liu T., Song K., Fan X., Ma X., Cui Z. Adipose-derived stem cell: a better stem cell than BMSC. Cell Biochemistry and Function. 2008;26(6):664–675. doi: 10.1002/cbf.1488.
    1. Mitchell J. B., McIntosh K., Zvonic S., et al. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. STEM CELLS. 2006;24(2):376–385. doi: 10.1634/stemcells.2005-0234.
    1. Guilak F., Lott K. E., Awad H. A., et al. Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. Journal of Cellular Physiology. 2006;206(1):229–237. doi: 10.1002/jcp.20463.
    1. Baer P. C., Geiger H. Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity. Stem Cells International. 2012;2012:11. doi: 10.1155/2012/812693.812693
    1. Van R. L. R., Bayliss C. E., Roncari D. A. K. Cytological and enzymological characterization of adult human adipocyte precursors in culture. The Journal of Clinical Investigation. 1976;58(3):699–704. doi: 10.1172/jci108516.
    1. Gimble J. M., Katz A. J., Bunnell B. A. Adipose-derived stem cells for regenerative medicine. Circulation Research. 2007;100(9):1249–1260. doi: 10.1161/01.res.0000265074.83288.09.
    1. Anitua E., Andia I., Ardanza B., Nurden P., Nurden A. T. Autologous platelets as a source of proteins for healing and tissue regeneration. Thrombosis and Haemostasis. 2004;91(1):4–15.
    1. Pak J., Chang J.-J., Lee J. H., Lee S. H. Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints. BMC Musculoskeletal Disorders. 2013;14, article 337 doi: 10.1186/1471-2474-14-337.
    1. Eppley B. L., Pietrzak W. S., Blanton M. Platelet-rich plasma: a review of biology and applications in plastic surgery. Plastic and Reconstructive Surgery. 2006;118(6):147e–159e. doi: 10.1097/.
    1. Fufa D., Shealy B., Jacobson M., Kevy S., Murray M. M. Activation of platelet-rich plasma using soluble type I collagen. Journal of Oral and Maxillofacial Surgery. 2008;66(4):684–690. doi: 10.1016/j.joms.2007.06.635.
    1. Pak J., Lee J. H., Lee S. H. A novel biological approach to treat chondromalacia patellae. PLoS ONE. 2013;8(5) doi: 10.1371/journal.pone.0064569.e64569
    1. Pak J., Lee J. H., Lee S. H. Regenerative repair of damaged meniscus with autologous adipose tissue-derived stem cells. BioMed Research International. 2014;2014:10. doi: 10.1155/2014/436029.436029
    1. Kim Y. S., Choi Y. J., Suh D. S., et al. Mesenchymal stem cell implantation in osteoarthritic knees: is fibrin glue effective as a scaffold? The American Journal of Sports Medicine. 2015;43(1):176–185. doi: 10.1177/0363546514554190.
    1. Uzuki M., Sawai T. A comparison of the affinity of sodium hyaluronate of various molecular weights for degenerated cartilage: a histochemical study using hyaluronic acid binding protein. International Congress Series. 2001;1223:279–284. doi: 10.1016/S0531-5131(01)00429-0.
    1. Benders K. E. M., Weeren P. R. V., Badylak S. F., Saris D. B. F., Dhert W. J. A., Malda J. Extracellular matrix scaffolds for cartilage and bone regeneration. Trends in Biotechnology. 2013;31(3):169–176. doi: 10.1016/j.tibtech.2012.12.004.
    1. Koh Y. G., Choi Y. J. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee steoarthritis. Knee. 2012;19(6):902–907. doi: 10.1016/j.knee.2012.04.001.
    1. Koh Y.-G., Jo S.-B., Kwon O.-R., et al. Mesenchymal stem cell injections improve symptoms of knee osteoarthritis. Arthroscopy. 2013;29(4):748–755. doi: 10.1016/j.arthro.2012.11.017.
    1. Bui K., Duong T., Nguyen N., et al. Symptomatic knee osteoarthritis treatment using autologous adipose derived stem cells and platelet-rich plasma: a clinical study. Biomedical Research and Therapy. 2014;1(1):2–8. doi: 10.7603/s40730-014-0002-9.
    1. Koh Y. G., Kwon O. R., Kim Y. S., Choi Y. J. Comparative outcomes of open-wedge high tibial osteotomy with platelet-rich plasma alone or in combination with mesenchymal stem cell treatment: a prospective study. Arthroscopy. 2014;30(11):1453–1460. doi: 10.1016/j.arthro.2014.05.036.
    1. Michalek J., Moster R., Lukac L., et al. Autologous adipose tissue-derived stromal vascular fraction cells application in patients with osteoarthritis. Cell Transplantation. In press.
    1. Dragoo J. L., Carlson G., McCormick F., et al. Healing full-thickness cartilage defects using adipose-derived stem cells. Tissue Engineering. 2007;13(7):1615–1621. doi: 10.1089/ten.2006.0249.
    1. Li Q., Tang J., Wang R., et al. Comparing the chondrogenic potential in vivo of autogeneic mesenchymal stem cells derived from different tissues. Artificial Cells, Blood Substitutes, and Biotechnology. 2011;39(1):31–38. doi: 10.3109/10731191003776769.
    1. Martin A. D., Daniel M. Z., Drinkwater D. T., Clarys J. P. Adipose tissue density, estimated adipose lipid fraction and whole body adiposity in male cadavers. International Journal of Obesity and Related Metabolic Disorders. 1994;18(2):79–83.
    1. Schreml S., Babilas P., Fruth S., et al. Harvesting human adipose tissue-derived adult stem cells: resection versus liposuction. Cytotherapy. 2009;11(7):947–957. doi: 10.3109/14653240903204322.
    1. Soriano R. A., Lamblet H., Mohammadi S. A., Torfi H. Optimization of Roche Liberase TM Research Grade (Highly Purified Collagenase) in the Enzymatic Digestion of Human Adipose Tissue for the Isolation of Stem and Regenerative Cells. Irvine, Calif, USA: Roche Diagnostic Cooperation; 2013. .
    1. Dregalla R. C., Lyons N. F., Reischling P. D., Centeno C. J. Amide-type local anesthetics and human mesenchymal stem cells: clinical implications for stem cell therapy. Stem Cells Translational Medicine. 2014;3(3):365–374. doi: 10.5966/sctm.2013-0058.
    1. LaBarbera K. E., Hyldahl R. D., O'Fallon K. S., Clarkson P. M., Witkowski S. Pericyte NF-κB activation enhances endothelial cell proliferation and proangiogenic cytokine secretion in vitro. Physiological Reports. 2015;3(4) doi: 10.14814/phy2.12309.e12309
    1. Díaz-Araya G., Vivar R., Humeres C., Boza P., Bolivar S., Muñoz C. Cardiac fibroblasts as sentinel cells in cardiac tissue: receptors, signaling pathways and cellular functions. Pharmacological Research. 2015;101:30–40. doi: 10.1016/j.phrs.2015.07.001.
    1. O’Carroll S. J., Kho D. T., Wiltshire R., et al. Pro-inflammatory TNFα and IL-1β differentially regulate the inflammatory phenotype of brain microvascular endothelial cells. Journal of Neuroinflammation. 2015;12, article 131 doi: 10.1186/s12974-015-0346-0.
    1. Moseley J. B., O'Malley K., Petersen N. J., et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. The New England Journal of Medicine. 2002;347(2):81–88. doi: 10.1056/nejmoa013259.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner